ALLO-316 in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC): updated safety and efficacy from the phase 1 TRAVERSE multicenter study
Publication Title
SITC Annual Meeting; November 6-10; Houston, TX. 2024;12(Suppl 2): 322
Document Type
Abstract
Publication Date
11-1-2024
Keywords
oregon; chiles
Area of Special Interest
Cancer
Area of Special Interest
Kidney & Diabetes
Specialty/Research Institute
Endocrinology
Specialty/Research Institute
Nephrology
Specialty/Research Institute
Oncology
Comments
Srour SA, Chahoud J, Drakaki A, Curti BD, Pal S, Tang L, Prashad S, Atwell J, Williams C, Ghatta S, Severyn CJ, Gall JL, Tannir NM, Kotecha RR